These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28195591)

  • 1. Correction: Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
    Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
    Org Biomol Chem; 2017 Mar; 15(9):2120-2121. PubMed ID: 28195591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
    Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
    Org Biomol Chem; 2016 Jul; 14(30):7226-37. PubMed ID: 27380866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of MUC1 glycopeptide thioesters and ligation via direct aminolysis.
    Wilkinson BL; Chun CK; Payne RJ
    Biopolymers; 2011; 96(2):137-46. PubMed ID: 20564042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
    Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
    Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
    Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
    Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: synthesis and antibiotic activity of oxazolidinone-catechol conjugates against Pseudomonas aeruginosa.
    Paulen A; Gasser V; Hoegy F; Perraud Q; Pesset B; Schalk IJ; Mislin GL
    Org Biomol Chem; 2015 Dec; 13(46):11401. PubMed ID: 26555129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3'-deoxy-3'-fluoro-Thomsen-Friedenreich antigen.
    Hoffmann-Röder A; Johannes M
    Chem Commun (Camb); 2011 Sep; 47(35):9903-5. PubMed ID: 21818465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of synthetic antitumour vaccines from mucin glycopeptide antigens.
    Gaidzik N; Westerlind U; Kunz H
    Chem Soc Rev; 2013 May; 42(10):4421-42. PubMed ID: 23440054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic and Immunological Studies of sTn Derivatives Carrying 5-N-(p-Substituted Phenylacetyl)Sialic Acid for the Development of Effective Cancer Vaccines.
    Wang Q; Guo Z
    ACS Med Chem Lett; 2011 May; 2(5):373-378. PubMed ID: 21691430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells.
    Leiria Campo V; Riul TB; Oliveira Bortot L; Martins-Teixeira MB; Fiori Marchiori M; Iaccarino E; Ruvo M; Dias-Baruffi M; Carvalho I
    Chembiochem; 2017 Mar; 18(6):527-538. PubMed ID: 28068458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
    Wu J; Guo Z
    Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Synthesis, self-aggregation and cryopreservation effects of perylene bisimide-glycopeptide conjugates.
    He X; Hu B; Yang Y; Zhu HY; Rong RX; Li XL; Wang KR
    Chem Commun (Camb); 2021 Nov; 57(93):12548. PubMed ID: 34779456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3 CysSerLys4.
    Shi L; Cai H; Huang ZH; Sun ZY; Chen YX; Zhao YF; Kunz H; Li YM
    Chembiochem; 2016 Aug; 17(15):1412-5. PubMed ID: 27188544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: A novel enantioselective synthesis of 6H-dibenzopyran derivatives by combined palladium/norbornene and cinchona alkaloid catalysis.
    Xu D; Dai L; Catellani M; Motti E; Della Ca' N; Zhou Z
    Org Biomol Chem; 2015 Feb; 13(8):2481. PubMed ID: 25629771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Synthesis of pyrrolidine-3-carboxylic acid derivatives via asymmetric Michael addition reactions of carboxylate-substituted enones.
    Yin F; Garifullina A; Tanaka F
    Org Biomol Chem; 2018 Apr; 16(16):3052-3053. PubMed ID: 29651476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy.
    Huang ZH; Shi L; Ma JW; Sun ZY; Cai H; Chen YX; Zhao YF; Li YM
    J Am Chem Soc; 2012 May; 134(21):8730-3. PubMed ID: 22587010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
    Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.